Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| FibroGen lands $40M milestone from Astellas - Bizjournals.com |
|
|
|
Bizjournals.com ... established clinical proof-of-concept, and screening for patients in the Phase IIb began in fourth-quarter 2010. Privately held FibroGen, based in San Francisco, said the drug is aimed at chronic kidney disease patients on dialysis or not on dialysis. FibroGen Announces Initiation of Phase 2b Studies of FG-4592, an Oral HIF |
Professional dialysis recruitment

